BioSpace News Archive

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, today announced financial and operating results for the third quarter ended September 30, 2021.

Corcept Therapeutics Incorporated today announced that the company will present at the following investor conferences: Jefferies London Healthcare Conference Date: Tuesday, November 16, 2021 Presentation Time: 5:00 pm GMT

IASO Biotherapeutics today announced that the updated data from Phase1/2 study of CT103A was accepted for an oral presentation at the 63rd American Society of Hematology (ASH) Annual Meeting, December 11-14, 2021 (Abstract # 547).

AmerisourceBergen today announced that it is now offering Prime Therapeutics’ IntegratedRx™ – Oncology program to eligible hospital, health system and independent oncology practice customers.

Omnicell, Inc. and pharmacies, and Fresenius Kabi are collaborating to provide U.S. hospitals and health systems with innovative new pharmacy technology designed to support safety and efficiency in dispensing of controlled substances in patient care areas.

IsoPlexis Corporation (Nasdaq: ISO), the leader in functional single-cell proteomics, today reported financial results for the quarter ended September 30, 2021.

OpSens Inc. (“OpSens” or the “Company”) (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company commercializing a second-generation fiber optic pressure guidewire to diagnose and treat coronary artery disease, announced today that Louis Laflamme, President and Chief Executive Officer will participate at the two following investment conferences.

Field data confirmed reduced incidence and severity of Fusarium wilt TR4 symptoms in banana plants after application of MustGrow’s product.

Entheon ID(TM) Clinical Study to Assess the Effect of Ketamine on Neurological Activity as Measured by EEG.

There are fundamental strides being made in both the early diagnosis and more effective therapeutic intervention that will better smooth the treatment journey for patients.